Elizabeth R. Smith

1.7k total citations
52 papers, 1.2k citations indexed

About

Elizabeth R. Smith is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Elizabeth R. Smith has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 19 papers in Cell Biology and 9 papers in Oncology. Recurrent topics in Elizabeth R. Smith's work include Microtubule and mitosis dynamics (13 papers), Nuclear Structure and Function (11 papers) and RNA Research and Splicing (7 papers). Elizabeth R. Smith is often cited by papers focused on Microtubule and mitosis dynamics (13 papers), Nuclear Structure and Function (11 papers) and RNA Research and Splicing (7 papers). Elizabeth R. Smith collaborates with scholars based in United States, Benin and Australia. Elizabeth R. Smith's co-authors include Xiang‐Xi Xu, Dong‐Hua Yang, EMMETT L. DURRUM, Kathy Q. Cai, Callinice D. Capo‐chichi, Junqi He, Jennifer L. Smedberg, Milton H. Paul, Isabelle Roland and Thomas C. Hamilton and has published in prestigious journals such as Science, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Elizabeth R. Smith

50 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth R. Smith United States 21 717 234 143 117 111 52 1.2k
S. Hauptmann Germany 20 668 0.9× 170 0.7× 346 2.4× 44 0.4× 133 1.2× 50 1.5k
Yunbae Pak South Korea 21 545 0.8× 330 1.4× 167 1.2× 39 0.3× 33 0.3× 49 1.0k
Kathryn Quinn Australia 16 580 0.8× 109 0.5× 142 1.0× 78 0.7× 69 0.6× 33 1.1k
Abbie Celniker United States 19 564 0.8× 82 0.4× 172 1.2× 220 1.9× 148 1.3× 29 1.8k
Arnaud Bruneel France 17 637 0.9× 118 0.5× 72 0.5× 60 0.5× 98 0.9× 54 1.3k
Yu Song China 20 535 0.7× 139 0.6× 144 1.0× 61 0.5× 48 0.4× 58 1.2k
Shinji Iwasaki Japan 22 530 0.7× 123 0.5× 353 2.5× 142 1.2× 122 1.1× 80 1.9k
Kenji Kawai Japan 19 515 0.7× 82 0.4× 244 1.7× 37 0.3× 83 0.7× 93 1.1k
R. Angelopoulou Greece 7 411 0.6× 39 0.2× 174 1.2× 81 0.7× 204 1.8× 14 906
Piotr Zawierucha Poland 16 521 0.7× 56 0.2× 279 2.0× 83 0.7× 62 0.6× 40 893

Countries citing papers authored by Elizabeth R. Smith

Since Specialization
Citations

This map shows the geographic impact of Elizabeth R. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth R. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth R. Smith more than expected).

Fields of papers citing papers by Elizabeth R. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth R. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth R. Smith. The network helps show where Elizabeth R. Smith may publish in the future.

Co-authorship network of co-authors of Elizabeth R. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth R. Smith. A scholar is included among the top collaborators of Elizabeth R. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth R. Smith. Elizabeth R. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Elizabeth R., et al.. (2025). The Persistent Power of the Taxane/Platin Chemotherapy. Cancers. 17(7). 1208–1208.
2.
Smith, Elizabeth R., et al.. (2024). Cancer nuclear envelope rupture and repair in taxane resistance. SHILAP Revista de lepidopterología. 4(6). 522–530. 1 indexed citations
3.
Smith, Elizabeth R., et al.. (2024). Cell death in cancer chemotherapy using taxanes. Frontiers in Pharmacology. 14. 1338633–1338633. 10 indexed citations
4.
Smith, Elizabeth R., et al.. (2023). Reassessing specificity/selectivity of taxane-based chemotherapy. 3(1). 37–48. 2 indexed citations
5.
Smith, Elizabeth R., et al.. (2022). Low Intensity Ultrasound as an Antidote to Taxane/Paclitaxel-induced Cytotoxicity. Journal of Cancer. 13(7). 2362–2373. 9 indexed citations
6.
Smith, Elizabeth R., et al.. (2022). Paclitaxel resistance related to nuclear envelope structural sturdiness. Drug Resistance Updates. 65. 100881–100881. 51 indexed citations
7.
Smith, Elizabeth R., Callinice D. Capo‐chichi, & Xiang‐Xi Xu. (2018). Defective Nuclear Lamina in Aneuploidy and Carcinogenesis. Frontiers in Oncology. 8. 529–529. 29 indexed citations
8.
Tao, Wensi, Robert H. Moore, Yue Meng, et al.. (2016). Disabled-2 Determines Commitment of a Pre-adipocyte Population in Juvenile Mice. Scientific Reports. 6(1). 35947–35947. 10 indexed citations
9.
Smith, Elizabeth R., et al.. (2016). Nuclear Envelope Defects in Epithelial Ovarian Cancer.
10.
Capo‐chichi, Callinice D., Toni M. Yeasky, Elizabeth R. Smith, & Xiang‐Xi Xu. (2016). Nuclear envelope structural defect underlies the main cause of aneuploidy in ovarian carcinogenesis. BMC Cell Biology. 17(1). 1–1. 29 indexed citations
11.
Tao, Wensi, Robert H. Moore, Elizabeth R. Smith, & Xiang‐Xi Xu. (2016). Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice. Frontiers in Cell and Developmental Biology. 4. 129–129. 30 indexed citations
12.
Smith, Elizabeth R., et al.. (2013). Cyclooxygenase-1 Inhibition Prolongs Postnatal Ovarian Follicle Lifespan in Mice1. Biology of Reproduction. 89(4). 103–103. 6 indexed citations
13.
14.
Yang, Dong‐Hua, Kathy Q. Cai, Isabelle Roland, Elizabeth R. Smith, & Xiang‐Xi Xu. (2007). Disabled-2 Is an Epithelial Surface Positioning Gene. Journal of Biological Chemistry. 282(17). 13114–13122. 65 indexed citations
15.
Smedberg, Jennifer L., Elizabeth R. Smith, Callinice D. Capo‐chichi, et al.. (2002). Ras/MAPK Pathway Confers Basement Membrane Dependence upon Endoderm Differentiation of Embryonic Carcinoma Cells. Journal of Biological Chemistry. 277(43). 40911–40918. 9 indexed citations
16.
Yang, Dong‐Hua, Elizabeth R. Smith, Isabelle Roland, et al.. (2002). Disabled-2 Is Essential for Endodermal Cell Positioning and Structure Formation during Mouse Embryogenesis. Developmental Biology. 251(1). 27–44. 140 indexed citations
17.
Smith, Elizabeth R., Callinice D. Capo‐chichi, Junqi He, et al.. (2001). Disabled-2 Mediates c-Fos Suppression and the Cell Growth Regulatory Activity of Retinoic Acid in Embryonic Carcinoma Cells. Journal of Biological Chemistry. 276(50). 47303–47310. 34 indexed citations
18.
Smith, Elizabeth R., J. E. Banatvala, & AntheaJ. Tilzey. (1996). Hepatitis B vaccine uptake among surgeons at a London teaching hospital: how well are we doing?. PubMed. 78(5). 447–9. 13 indexed citations
19.
Misan, Gary, et al.. (1990). Drug utilization review in a teaching hospital: experience with vancomycin. European Journal of Clinical Pharmacology. 39(5). 457–61. 24 indexed citations
20.
Nury, Fred S. & Elizabeth R. Smith. (1957). Alpha- and Beta-Lipoprotein Cholesterol. Clinical Chemistry. 3(2). 110–115. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026